Abstract
For centuries, lichens have been used in traditional medicine and their use persists to the present day in some parts of the world. Depsidones are one of the classes of secondary metabolites which are mostly produced in lichens. Lichen depsidones have been reported to possess many biological activities, such as antitumor and antimicrobial activities. In order to point out the pharmacological potential of this class of compounds, the present article reviews the structure and biological properties of the known lichen depsidones. The biosynthesis of depsidones and the relationship between their chemical structure and biological activity is also discussed.
Keywords: Biological activity, biosynthesis, depsidones, lichen, structure-activity relationship, Cyrenespora cassiicola, Garcinisidones, M14 cell line, Vicanicin, Lobaric acid
Mini-Reviews in Organic Chemistry
Title:Lichen Depsidones as Potential Novel Pharmacologically Active Compounds
Volume: 9 Issue: 2
Author(s): Gordana Stojanovic, Igor Stojanovic and Andrija Smelcerovic
Affiliation:
Keywords: Biological activity, biosynthesis, depsidones, lichen, structure-activity relationship, Cyrenespora cassiicola, Garcinisidones, M14 cell line, Vicanicin, Lobaric acid
Abstract: For centuries, lichens have been used in traditional medicine and their use persists to the present day in some parts of the world. Depsidones are one of the classes of secondary metabolites which are mostly produced in lichens. Lichen depsidones have been reported to possess many biological activities, such as antitumor and antimicrobial activities. In order to point out the pharmacological potential of this class of compounds, the present article reviews the structure and biological properties of the known lichen depsidones. The biosynthesis of depsidones and the relationship between their chemical structure and biological activity is also discussed.
Export Options
About this article
Cite this article as:
Stojanovic Gordana, Stojanovic Igor and Smelcerovic Andrija, Lichen Depsidones as Potential Novel Pharmacologically Active Compounds, Mini-Reviews in Organic Chemistry 2012; 9 (2) . https://dx.doi.org/10.2174/157019312800604689
DOI https://dx.doi.org/10.2174/157019312800604689 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Doxycycline in Mitochondrial Mediated Pathway of Apoptosis: A Systematic Review
Anti-Cancer Agents in Medicinal Chemistry Phytochemistry and Pharmacognosy of Naturally Occurring Prenyloxyanthraquinones
Current Drug Targets Biofunctional Peptides from Milk Proteins: Mineral Binding and Cytomodulatory Effects
Current Pharmaceutical Design Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency
Current Gene Therapy Glioblastoma Multiforme and its Cell Interruption
Current Cancer Therapy Reviews The Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma Multiforme and other Malignant Neoplasms
Anti-Cancer Agents in Medicinal Chemistry Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Current Stem Cell Research & Therapy Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Current Drug Targets Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism Plant Cells as Pharmaceutical Factories
Current Pharmaceutical Design Bid Stands at the Crossroad of Stress-Response Pathways
Current Cancer Drug Targets Cellomics as Integrative Omics for Cancer
Current Proteomics The Need for Diagnostic Criteria in Systemic Vasculitis
Current Immunology Reviews (Discontinued) Beyond Single Pathway Inhibition: MEK Inhibitors as a Platform for the Development of Pharmacological Combinations with Synergistic Anti-Leukemic Effects
Current Pharmaceutical Design Targeted Radionuclide Therapy - An Overview
Current Radiopharmaceuticals Intracellular Routing of Cytotoxic Pancreatic-Type Ribonucleases
Current Pharmaceutical Biotechnology Factors Controlling Chromatin Organization and Nucleosome Positioning for Establishment and Maintenance of HIV Latency
Current HIV Research “Momordica balsamina: A Medicinal and Neutraceutical Plant for Health care Management”. Comments: Biotechnological Potential of M. balsamina Revealed
Current Pharmaceutical Biotechnology Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry